Dae- Won Kim - Search Results

Year	Number of Results
2002	3
2003	9
2004	12
2005	19
2006	22
2007	20
2008	32
2009	33
2010	32
2011	30
2012	27
2013	32
2014	40
2015	36
2016	50
2017	40
2018	40
2019	44
2020	52
2021	58
2022	34
2023	38
2024	12

1

Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy.

Kim DW, Talati C, Kim R. Kim DW, et al. J Gastrointest Oncol. 2017 Apr;8(2):256-265. doi: 10.21037/jgo.2016.09.07. J Gastrointest Oncol. 2017. PMID: 28480065 Free PMC article. Review.

2

Uveal melanoma: From diagnosis to treatment and the science in between.

Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, Patel SP. Chattopadhyay C, et al. Among authors: kim dw. Cancer. 2016 Aug 1;122(15):2299-312. doi: 10.1002/cncr.29727. Epub 2016 Mar 15. Cancer. 2016. PMID: 26991400 Free PMC article. Review.

3

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer.

Kim RD, Chung V, Alese OB, El-Rayes BF, Li D, Al-Toubah TE, Schell MJ, Zhou JM, Mahipal A, Kim BH, Kim DW. Kim RD, et al. Among authors: kim dw. JAMA Oncol. 2020 Jun 1;6(6):888-894. doi: 10.1001/jamaoncol.2020.0930. JAMA Oncol. 2020. PMID: 32352498 Free PMC article. Clinical Trial.

4

Immunotherapy for uveal melanoma.

Kim DW, Anderson J, Patel SP. Kim DW, et al. Melanoma Manag. 2016 Jun;3(2):125-135. doi: 10.2217/mmt-2015-0006. Epub 2016 May 19. Melanoma Manag. 2016. PMID: 30190881 Free PMC article. Review.

5

Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma.

Sarfraz H, Saha A, Jhaveri K, Kim DW. Sarfraz H, et al. Among authors: kim dw. Curr Oncol. 2023 May 26;30(6):5322-5336. doi: 10.3390/curroncol30060404. Curr Oncol. 2023. PMID: 37366887 Free PMC article. Review.

6

Improving clinical outcomes with pembrolizumab in patients with advanced melanoma.

Kim DW, Zager JS, Eroglu Z. Kim DW, et al. Chin Clin Oncol. 2017 Feb;6(1):2. doi: 10.21037/cco.2017.01.04. Chin Clin Oncol. 2017. PMID: 28285535 Free article. No abstract available.

7

A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer.

Kim RD, Kovari BP, Martinez M, Xie H, Sahin IH, Mehta R, Strosberg J, Imanirad I, Ghayouri M, Kim YC, Kim DW. Kim RD, et al. Among authors: kim dw. Eur J Cancer. 2022 Jul;169:93-102. doi: 10.1016/j.ejca.2022.03.026. Epub 2022 May 5. Eur J Cancer. 2022. PMID: 35526308 Clinical Trial.

8

Entacapone promotes hippocampal neurogenesis in mice.

Yoo DY, Jung HY, Kim W, Hahn KR, Kwon HJ, Nam SM, Chung JY, Yoon YS, Kim DW, Hwang IK. Yoo DY, et al. Among authors: kim dw. Neural Regen Res. 2021 Jun;16(6):1005-1110. doi: 10.4103/1673-5374.300447. Neural Regen Res. 2021. PMID: 33269743 Free PMC article.

9

Profile of selumetinib and its potential in the treatment of melanoma.

Kim DW, Patel SP. Kim DW, et al. Onco Targets Ther. 2014 Sep 19;7:1631-9. doi: 10.2147/OTT.S51596. eCollection 2014. Onco Targets Ther. 2014. PMID: 25278770 Free PMC article. Review.

10

Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer.

Bibok A, Kim DW, Malafa M, Kis B. Bibok A, et al. Among authors: kim dw. World J Gastroenterol. 2021 Jul 21;27(27):4322-4341. doi: 10.3748/wjg.v27.i27.4322. World J Gastroenterol. 2021. PMID: 34366607 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

643 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

643 results

Results by year